Copper/Cholesterol Interaction in Alzheimer's Disease
Principal Investigator
Ashley Bush, M.B.B.S., Ph.D.
Mental Health Research Institute
Parkville, Australia
About the Research Project
Program
Award Type
Standard
Award Amount
$300,000
Active Dates
April 01, 2005 - March 31, 2007
Grant ID
A2005091
Summary
In Alzheimer’s disease a normal protein called beta-amyloid (Aβ) has been found to accumulate abnormally in the brain. AD has also been associated with abnormalities in cholesterol metabolism. Both links, however, are complex and the results of their specific effects have not yet been pin-pointed. Dr. Bush’s team has discovered Aβ to be a copper binding protein. Copper (like cholesterol) is a normally abundant part of brain chemistry, but in AD Aβ abnormally utilizes copper’s chemical energy to convert cholesterol into hydrogen peroxide. This is a damaging reaction that may be the cause of the toxicity of Aβ. Through a five part research analysis, Dr. Bush’s studies will help illuminate the complex biochemistry of Aβ in its reactions with copper and cholesterol in the brain.
Related Grants
Alzheimer's Disease Research
The Effects of Peripheral APOE2 on Alzheimer’s Disease Pathology and Pathways
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Guojun Bu, PhD
Current Organization
Hong Kong University of Science and Technology
The Effects of Peripheral APOE2 on Alzheimer’s Disease Pathology and Pathways
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Guojun Bu, PhD
Current Organization
Hong Kong University of Science and Technology
Alzheimer's Disease Research
Abca1 Regulates Lipid Metabolism and Tau Pathology in P301S/ApoE4 Mice
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Alexandra Litvinchuk, PhD
Current Organization
Washington University in St. Louis
Abca1 Regulates Lipid Metabolism and Tau Pathology in P301S/ApoE4 Mice
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Alexandra Litvinchuk, PhD
Current Organization
Washington University in St. Louis
Alzheimer's Disease Research
Dysfunction of the Regulation of Cerebral Blood Flow in Alzheimer Disease
Active Dates
July 01, 2022 - June 30, 2025
Principal Investigator
Antoine Anfray, PhD
Current Organization
Weill Medical College of Cornell University
Dysfunction of the Regulation of Cerebral Blood Flow in Alzheimer Disease
Active Dates
July 01, 2022 - June 30, 2025
Principal Investigator
Antoine Anfray, PhD
Current Organization
Weill Medical College of Cornell University